33.98
price down icon4.17%   -1.4895
 
loading
Precedente Chiudi:
$35.47
Aprire:
$35.16
Volume 24 ore:
1.05M
Relative Volume:
0.36
Capitalizzazione di mercato:
$5.39B
Reddito:
$264.79M
Utile/perdita netta:
$-14.36M
Rapporto P/E:
-308.91
EPS:
-0.11
Flusso di cassa netto:
$-28.11M
1 W Prestazione:
+1.77%
1M Prestazione:
-8.06%
6M Prestazione:
-1.62%
1 anno Prestazione:
+104.76%
Intervallo 1D:
Value
$33.76
$35.18
Intervallo di 1 settimana:
Value
$33.11
$35.62
Portata 52W:
Value
$15.16
$46.48

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name
Nome
Tg Therapeutics Inc
Name
Telefono
(212) 554-4484
Name
Indirizzo
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Name
Dipendente
352
Name
Cinguettio
@TGTherapeutics
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
TGTX's Discussions on Twitter

Confronta TGTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TGTX
Tg Therapeutics Inc
33.96 5.30B 264.79M -14.36M -28.11M -0.11
Biotechnology icon
ONC
Beigene Ltd Adr
235.79 24.29B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
436.02 110.94B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3064 45.05M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
600.72 61.99B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.51 5.75B 0 -153.72M -103.81M -2.00

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-10-29 Iniziato TD Cowen Buy
2023-08-02 Aggiornamento Goldman Sell → Neutral
2023-06-26 Ripresa Jefferies Buy
2022-05-20 Iniziato BofA Securities Underperform
2022-02-23 Reiterato B. Riley Securities Buy
2021-11-15 Downgrade Goldman Neutral → Sell
2021-04-20 Iniziato Goldman Neutral
2021-04-19 Reiterato H.C. Wainwright Buy
2020-09-01 Iniziato JP Morgan Overweight
2020-08-11 Reiterato H.C. Wainwright Buy
2020-06-05 Iniziato Evercore ISI Outperform
2020-01-17 Reiterato H.C. Wainwright Buy
2019-11-27 Ripresa B. Riley FBR Buy
2019-02-06 Ripresa Jefferies Buy
2018-09-25 Downgrade Raymond James Strong Buy → Outperform
2018-03-09 Reiterato B. Riley FBR, Inc. Buy
2017-12-01 Ripresa B. Riley FBR, Inc. Buy
2017-11-14 Ripresa H.C. Wainwright Buy
2017-04-25 Iniziato Jefferies Buy
2017-03-06 Reiterato FBR & Co. Outperform
2016-10-06 Ripresa Brean Capital Buy
2016-05-27 Iniziato SunTrust Buy
2015-12-01 Iniziato FBR Capital Outperform
2015-09-09 Iniziato Raymond James Strong Buy
2015-08-12 Ripresa H.C. Wainwright Buy
2015-06-19 Reiterato Brean Capital Buy
2014-12-11 Reiterato ROTH Capital Buy
2014-12-10 Reiterato ROTH Capital Buy
Mostra tutto

Tg Therapeutics Inc Borsa (TGTX) Ultime notizie

pulisher
07:19 AM

Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st

07:19 AM
pulisher
May 16, 2025

TG Therapeutics' (NASDAQ:TGTX) Weak Earnings May Only Reveal A Part Of The Whole Picture - simplywall.st

May 16, 2025
pulisher
May 16, 2025

Investor Calendar Invites You to the TG Therapeutics, Inc. Third Quarter 2016 Earnings Conference Call and Webcast Live on Monday, November 7, 2016 - ACCESS Newswire

May 16, 2025
pulisher
May 15, 2025

(TGTX) Long Term Investment Analysis - news.stocktradersdaily.com

May 15, 2025
pulisher
May 13, 2025

TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook - MSN

May 13, 2025
pulisher
May 10, 2025

Decoding TG Therapeutics Inc (TGTX): A Strategic SWOT Insight - GuruFocus

May 10, 2025
pulisher
May 09, 2025

TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN

May 08, 2025
pulisher
May 07, 2025

TG Therapeutics stock sinks on profit miss - MSN

May 07, 2025
pulisher
May 06, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 06, 2025
pulisher
May 06, 2025

TG Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Str - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Jefferies maintains Buy on TGTX stock with $46 target By Investing.com - Investing.com Nigeria

May 06, 2025
pulisher
May 06, 2025

TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... By GuruFocus - Investing.com Canada

May 06, 2025
pulisher
May 06, 2025

TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook By Stocktwits - Investing.com India

May 06, 2025
pulisher
May 05, 2025

TG Therapeutics: Q1 Earnings Snapshot - MySA

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show - Benzinga

May 05, 2025
pulisher
May 05, 2025

Why TG Therapeutics Stock Was Tumbling Today - AOL.com

May 05, 2025
pulisher
May 05, 2025

TGTX Stock Dips Despite Surging Revenue and Profitability - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Jefferies maintains Buy on TGTX stock with $46 target - Investing.com

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges (TGTX) - Seeking Alpha

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics (TGTX) Stock Falls After Earnings Miss Despite Raised Guidance - GuruFocus

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics stock sinks on profit miss (TGTX:NASDAQ) - Seeking Alpha

May 05, 2025
pulisher
May 05, 2025

Strong Q1 Performance for TG Therapeutics (TGTX) with BRIUMVI Growth - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Earnings call transcript: TG Therapeutics misses Q1 2025 EPS forecast, shares dip - Investing.com

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics Stock Tumbles After Q1 Earnings Fall Short Of Wall Street Estimates: But Retail’s Optimistic - MSN

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics (TGTX) Lags Q1 Earnings Estimates - Yahoo Finance

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance - GlobeNewswire

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics (TGTX) Misses Q1 EPS Estimates, Raises 2025 Reve - GuruFocus

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics Inc (TGTX) Reports Q1 2025 Revenue of $119.7 Million, Surpassing Estimates - GuruFocus

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics' Q1 Swings to Net Income, Revenue Rises; Full-Year 2025 BRIUMVI Revenue Guidance Updated - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics Reports First Quarter 2025 Financial Results - TradingView

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance | TGTX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics Q1 revenue beats estimates, stock edges higher By Investing.com - Investing.com Canada

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics Q1 revenue beats estimates, stock edges higher - Investing.com

May 05, 2025
pulisher
May 05, 2025

TGTX Surpasses Revenue Expectations with Strong Q1 Performance | TGTX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Earnings Flash (TGTX) TG Therapeutics Posts Q1 EPS $0.03, vs. FactSet Est of $0.17 - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

Earnings Flash (TGTX) TG Therapeutics Reports Q1 Revenue $120.9M, vs. FactSet Est of $117.9M - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 05, 2025
pulisher
May 05, 2025

TG Therapeutics Earnings Loom With Stock (NASDAQ: TGTX) Outperforming Market - AskTraders.com

May 05, 2025
pulisher
May 04, 2025

When (TGTX) Moves Investors should Listen - news.stocktradersdaily.com

May 04, 2025
pulisher
May 03, 2025

TG Therapeutics (TGTX) Schedules Q1 2025 Earnings Call - GuruFocus

May 03, 2025
pulisher
May 02, 2025

TG Therapeutics (TGTX) Poised for Major Earnings Growth in Q1 - GuruFocus

May 02, 2025
pulisher
Apr 30, 2025

TG Therapeutics stock soars to 52-week high of $45.28 By Investing.com - Investing.com India

Apr 30, 2025
pulisher
Apr 30, 2025

TG Therapeutics stock soars to 52-week high of $45.28 - Investing.com

Apr 30, 2025
pulisher
Apr 30, 2025

TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

TG Therapeutics to Host Conference Call on First Quarter 2025 Fi - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update | TGTX Stock News - GuruFocus

Apr 30, 2025

Tg Therapeutics Inc Azioni (TGTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.30
price down icon 0.76%
$32.65
price down icon 0.56%
$590.07
price up icon 2.08%
$291.74
price down icon 0.04%
$4.25
price up icon 0.00%
$74.87
price up icon 0.21%
Capitalizzazione:     |  Volume (24 ore):